105 related articles for article (PubMed ID: 22173152)
1. Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients.
Sebagh M; Samuel D; Antonini TM; Coilly A; Degli Esposti D; Roche B; Karam V; Dos Santos A; Duclos-Vallée JC; Roque-Afonso AM; Ballot E; Guettier C; Blandin F; Saliba F; Azoulay D
J Hepatol; 2012 Apr; 56(4):840-7. PubMed ID: 22173152
[TBL] [Abstract][Full Text] [Related]
2. All liver recipients benefit from the protocol 10-year liver biopsies.
Sebagh M; Rifai K; Féray C; Yilmaz F; Falissard B; Roche B; Bismuth H; Samuel D; Reynès M
Hepatology; 2003 Jun; 37(6):1293-301. PubMed ID: 12774007
[TBL] [Abstract][Full Text] [Related]
3. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
Abraham SC; Poterucha JJ; Rosen CB; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2008 Jul; 32(7):965-73. PubMed ID: 18460980
[TBL] [Abstract][Full Text] [Related]
4. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
5. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
6. Are posttransplantation protocol liver biopsies useful in the long term?
Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
[TBL] [Abstract][Full Text] [Related]
7. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Firpi RJ; Abdelmalek MF; Soldevila-Pico C; Cabrera R; Shuster JJ; Theriaque D; Reed AI; Hemming AW; Liu C; Crawford JM; Nelson DR
Liver Transpl; 2004 Oct; 10(10):1240-7. PubMed ID: 15376304
[TBL] [Abstract][Full Text] [Related]
8. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
9. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
10. Late protocol liver biopsies in the liver allograft: a neglected investigation?
Mells G; Mann C; Hubscher S; Neuberger J
Liver Transpl; 2009 Aug; 15(8):931-8. PubMed ID: 19642126
[TBL] [Abstract][Full Text] [Related]
11. Graft fibrosis after pediatric liver transplantation: ten years of follow-up.
Scheenstra R; Peeters PM; Verkade HJ; Gouw AS
Hepatology; 2009 Mar; 49(3):880-6. PubMed ID: 19101912
[TBL] [Abstract][Full Text] [Related]
12. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
Myers RP; Pomier-Layrargues G; Kirsch R; Pollett A; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
J Hepatol; 2012 Mar; 56(3):564-70. PubMed ID: 22027584
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
14. The long-term liver graft and protocol biopsy: do we want to look? What will we find?
Ekong UD
Curr Opin Organ Transplant; 2011 Oct; 16(5):505-8. PubMed ID: 21836515
[TBL] [Abstract][Full Text] [Related]
15. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients.
Lee VS; Miller FH; Omary RA; Wang Y; Ganger DR; Wang E; Rao S; Levitsky J
Transplantation; 2011 Sep; 92(5):581-6. PubMed ID: 21822174
[TBL] [Abstract][Full Text] [Related]
17. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.
Vergniol J; Foucher J; Terrebonne E; Bernard PH; le Bail B; Merrouche W; Couzigou P; de Ledinghen V
Gastroenterology; 2011 Jun; 140(7):1970-9, 1979.e1-3. PubMed ID: 21376047
[TBL] [Abstract][Full Text] [Related]
19. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
[TBL] [Abstract][Full Text] [Related]
20. Significance of central perivenulitis in pediatric liver transplantation.
Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
